Physician

Raam Sambandam, M.D.

According to 2025 Medicare claims, Raam Sambandam, M.D. (NPI: 1528226388) practices neurology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is SYNAPSE NEUROLOGICAL CARE P.A. (NPI: 1124469218; TIN: 38-3898623) and primary practice location at 34711-1915. Sambandam is affiliated with the UF HEALTH ACO GAINESVILLE, LLC (ACO ID: A5468), participating under the MSSP model.

Sambandam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 897 traditional Medicare patients, billed 317,433 HCPCS/CPT codes, and received $3,731,054 in Medicare payments. The top billing code was 95912 (Nerve conduction, 11-12 studies). Part D data shows 3,883 prescription claims across 791 beneficiaries totaling $4,549,146 in drug costs, led by Gammaked (Immune Globul G/Gly/Iga Avg 46). Open Payments data shows 302 records totaling $24,728. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $170,109 to $3,731,054. Similarly, Part D prescription costs have risen steadily, from $472,861 to $4,549,146. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	496	2,417	$170,109
2016	666	3,015	$225,486
2017	754	4,514	$206,996
2018	768	8,658	$218,750
2019	692	7,098	$227,243
2020	739	16,164	$498,436
2021	1,130	49,091	$1,813,992
2022	970	52,115	$1,937,828
2023	785	91,240	$1,977,577
2024	897	317,433	$3,731,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	343	2,034	$472,861
2016	487	2,955	$1,631,080
2017	612	3,899	$3,138,224
2018	675	4,958	$4,282,002
2019	726	4,977	$3,477,804
2020	872	6,554	$5,856,233
2021	999	7,622	$7,606,182
2022	816	3,531	$5,430,293
2023	702	3,462	$4,696,161
2024	791	3,883	$4,549,146

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95912	Nerve conduction, 11-12 studies	89	91	$198
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	153	153	$173
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	703	1,707	$98
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	122	260	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	409	822	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammaked	Immune Globul G/Gly/Iga Avg 46	80	1,744	$1,003,860
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	20	497	$937,498
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	68	1,428	$416,967
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	18	504	$248,174
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	22	518	$142,135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	302	$24,728	ARGENX US, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Raam Sambandam, M.D.?

Tedicare shows public-source Medicare data for Raam Sambandam, M.D. (NPI 1528226388), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raam Sambandam, M.D. have ACO affiliation data?

Raam Sambandam, M.D. is shown with ACO affiliation data for UF HEALTH ACO GAINESVILLE, LLC (MSSP, ACO ID A5468).

What billing organization is linked to Raam Sambandam, M.D.?

Raam Sambandam, M.D. is linked to SYNAPSE NEUROLOGICAL CARE P.A. (billing NPI 1124469218) in the available physician profile data.

Does Raam Sambandam, M.D. have Open Payments data?

Raam Sambandam, M.D. has 302 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.